ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 15 of 59
Up
JMBS 2020, 5(5): 133–141
https://doi.org/10.26693/jmbs05.05.133
Clinical Medicine

Opioid-Free Analgosedation during Coronary Artery Stenting

Dziuba D. 1,2, Nedashkivskij S. 1, Chubko V. 2, Loskutov O. 1
Abstract

The widespread usage of opioids / opiates in anesthetic practice has highlighted a number of related problems. Therefore, in recent years, the concept of opiate-free anesthesia has been gaining popularity among anesthesiologists around the world. In this context, we are interested in lidocaine as a component of this anesthesia. The attention of anesthesiologists to lidocaine during analgesia is due to its analgesic, anti-inflammatory and antihyperalgesic properties. The basis of the analgesic effect of the drug is that it blocks sodium channels and depolarizes nociceptive peripheral neurons, simultaneously inhibits NMDA receptors, reduces the number of cytokine complexes circulating in the plasma, and dissociates the Gq protein. In general, these properties lead to a decrease in opiate consumption, an acceleration of rehabilitation, a decrease in episodes of nausea and vomiting, a reduction in hospital stay, and even has certain neuroprotective properties. The purpose of our work was to establish the main aspects of non-opiate anesthesia usage that was based on lidocaine during coronary stenting. Material and methods. We studied 60 patients with coronary artery disease who underwent stenting of the coronary arteries in a planned manner. The main diagnosis was exertional angina FC II-III. In terms of the duration of the surgery, it was 38.54±19.3 minutes, and the number of stents was 1.3±0.7. The patients were evenly divided into two study groups, depending on the prescribed drug regimen. The first group included patients who were sedated by slow intravenous administration of diazepam and fentanyl. In the group of non-opiate anesthesia, a lidocaine solution was the main component of analgesia. At the stages before the start of the surgery, during the main stage, namely, the stent placement, and after the end of the surgery, the parameters of hemodynamics, saturation, gas and electrolyte composition of blood, the level of glycemia and cortisol were assessed. Results and discussion. The main complaint of patients in the control group was drowsiness, which was noted by 36.7% of patients. We attribute this feature to the use of diazepam. However, drowsiness was also noted in 33.3% of the experimental group after surgery. This fact can be explained by the use of significant doses of propofol, which were needed to maintain hemodynamics at the appropriate level. Episodes of nausea and vomiting may occur during surgery, especially when using opiates with a high probability. The phenomena of nausea were observed in 13.4% of the 1st group, and in the 2nd group it occurred in 3.3% of cases. According to the recommendations, we administered 4 mg of ondasetron solution after which the nausea disappeared. In the second group, complaints related to the local anesthetic effects of lidocaine came to the fore. 63.3% complained of "crawling ants" or numbness in the hand, the same sensations in the cheek and numbness of the tongue – 33.3%. After the operation, the feeling of numbness in the hand persisted in 16.7%. It should be noted that these sensations did not cause significant discomfort and did not interfere with anesthesia. Conclusion. In the course of the work, we came to the conclusion that the usage of lidocaine at a dose of 1 mg / kg of the patient's body weight is safe for coronary artery stenting operations and, at the same time, there are no negative effects inherent in opiate based anesthesia. At the same time, the local anesthetic effects after using lidocaine do not worsen the course of the postoperative period

Keywords: coronary artery stenting, opioid-free anesthesia, diazepam, fentanyl, lidocaine

Full text: PDF (Ukr) 310K

References
  1. Beloeil H. Opioid-free anesthesia. Best Pract Res Clin Anaesthesiol. 2019 Sep; 33(3): 353-360. https://doi.org/10.1016/j.bpa.2019.09.002
  2. Aziz AM, Paesmans M, et al. Opioid-free anesthesia: what about patient comfort? A prospective, randomized, controlled trial. Acta Anaesthesiol Belg. 2016; 67(4): 183-190.
  3. Lavand'homme P, Arnaud S. Opioid-free anesthesia opioid side effects: tolerance and hyperalgesia. Best Pract Res Clin Anaesthesiol. 2017; 31(4): 487-498. https://doi.org/10.1016/j.bpa.2017.05.003
  4. Lavand'homme P, Estebe J-P. Opioid-free anesthesia: a different regard to anesthesia practice. Current Opinion in Anesthesiology. 2018; 31(5): 556-561. https://doi.org/10.1097/ACO.0000000000000632
  5. Mauermann E, Ruppen W, Bandschapp O. Different protocols used today to achieve total opioid-free general anesthesia without locoregional blocks. Best Pract Res Clin Anaesthesiol. 2017; 31(4): 533-545. https://doi.org/10.1016/j.bpa.2017.11.003
  6. Hill R, Santhakumar R, Dewey W, Kelly E, Henderson G. Fentanyl depression of respiration: comparison with heroin and morphine. British Journal of Pharmacology. 2020; 177(2): 254-265. https://doi.org/10.1111/bph.14860
  7. Montandon G, and Horner RL. Electrocortical changes associating sedation and respiratory depression by the opioid analgesic fentanyl. Scientific reports. 2019; 9(1): 1-11. https://doi.org/10.1038/s41598-019-50613-2
  8. Sacerdote P, Franchi S, Panerai AE. Non-analgesic effects of opioids: mechanisms and potential clinical relevance of opioid-induced immunodepression. Current pharmaceutical design. 2012; 18: 6034-42. https://doi.org/10.2174/138161212803582496
  9. Centers for Disease Control and Prevention. Drug overdose deaths in the United States continue to increase in 2015. 2017 Aug 3. Available from: www.cdc.gov/drugoverdose/epidemic/index.html
  10. Fecho K, Lunney AT, Boysen PG, Rock P, Norfleet EA. Postoperative mortality after inpatient surgery: incidence and risk factors. Ther Clin Risk Manag. 2008 Aug; 4(4): 681-688. https://doi.org/10.2147/TCRM.S2735
  11. Platt S, Raedle J. The opioid crisis in the USA: a public health emergency. Lancet. 2017; 390(10107): 2016. https://doi.org/10.1016/S0140-6736(17)32808-8
  12. Yaster M, Benzon HT, Anderson TA. Houston, we have a problem! The role of the anesthesiologist in the current opioid epidemic. Anesth Analg. 2017; 125: 1429-1431. https://doi.org/10.1213/ANE.0000000000002395
  13. Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, et al. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg. 2017; 152(6): e170504. https://doi.org/10.1001/jamasurg.2017.0504
  14. Lundy JS. Balanced anesthesia. Minnesota Med. 1926; 9: 399-404.
  15. Kehlet H, Dahl JB. The value of "multimodal" or "balanced analgesia" in postoperative pain treatment. Anesth Analg. 1993 Nov; 77(5): 1048-1056. https://doi.org/10.1213/00000539-199311000-00030
  16. Woolf CJ, Chong MS. Preemptive analgesia-treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg. 1993 Aug; 77(2): 362-379. https://doi.org/10.1213/00000539-199377020-00026
  17. Lavand'homme P, de Kock M, Waterloos H. Intraoperative epidural analgesia combined with ketamine provides effective preventive analgesia in patients undergoing major digestive surgery. Anesthesiology. 2005; 103: 813-20. https://doi.org/10.1097/00000542-200510000-00020
  18. Dzyuba DO, Dzyuba HA, Chyr'yeva OM. Vplyv epiduralnoi anesteziyi pry endovaskulyarniy embolizatsiyi matkovykh arteriy na perebih pislyaoperatsiynoho periodu [Influence of epidural anesthesia during endovascular embolization of uterine arteries on the course of the postoperative period]. Ukraina. Zdorov'ya natsiyi. 2015; 3(35): 121-123. [Ukrainian]
  19. Dzyuba DO, Nedashkivskyi SM, Zlochevskyi OM. Varianty peryoperatsiynoho znebolyuvannya khvorykh iz krytychnoyu ishemiyeyu nyzhnikh kintsivok, sho prooperovani metodom endovaskulyarnoi balonoplastyky [Variants of perioperative anesthesia in patients with critical lower extremity ischemia operated by endovascular balloon plastics]. Medytsyna neotlozhnykh sostoyanyi. 2016; 3(74): 72-74. [Ukrainian] https://doi.org/10.22141/2224-0586.3.74.2016.77522
  20. Boysen PhG, Pappas MM, Evans B. An evidence-based opioid-free anesthetic technique to manage perioperative and periprocedural pain. Ochsner Journal. 2018; 18(2): 121-125. https://doi.org/10.31486/toj.17.0072
  21. Mulier J, Dekock, M Opioid free general anesthesia, a new paradigm? Best Pract Res Clin Anaesthesiol. 2017; 31(4): 441-443. https://doi.org/10.1016/j.bpa.2017.11.005
  22. Greenwood E, Nimmo S, Paterson H, Homer N, Foo I. Intravenous lidocaine infusion as a component of multimodal analgesia for colorectal surgery - measurement of plasma levels. Perioperative Medicine. 2019; 8(1): 1. https://doi.org/10.1186/s13741-019-0112-4
  23. Clattenburg E, Nguyen A, Yoo T, Flores St, Hailozian Ch, Louie D, et al. Intravenous lidocaine provides similar analgesia to intravenous morphine for undifferentiated severe pain in the emergency department: a pilot, unblinded randomized controlled trial. Pain Medicine. 2019; 20(4): 834-839. https://doi.org/10.1093/pm/pny031
  24. Vigneault L, Turgeon AF, Côté D, Lauzier F, Zarychanski R, Moore L, et al. Perioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trials. Can J Anaesth. 2011 Jan; 58(1): 22-37. https://doi.org/10.1007/s12630-010-9407-0
  25. Yardeni IZ, Beilin B, Mayburd E, Levinson Y, Bessler H. The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg. 2009 Nov; 109(5): 1464-1469. https://doi.org/10.1213/ANE.0b013e3181bab1bd
  26. Chiu KM, Lu CW, Lee MY, Wang MJ, Lin TY, Wang SJ. Neuroprotective and anti-inflammatory effects of lidocaine in kainic acid-injected rats. Neuroreport. 2016; 27(7): 501-507. https://doi.org/10.1097/WNR.0000000000000570
  27. Lin S, Jin P, Shao C, Lu W, Xiang Q, Jiang Z, et al. Lidocaine attenuates lipopolysaccharide-induced inflammatory responses and protects against endotoxemia in mice by suppressing HIF1α-induced glycolysis. International Immunopharmacology. 2020; 80. https://doi.org/10.1016/j.intimp.2019.106150
  28. Okada S, Hagan JB, Kato M, Bankers-Fulbright JL, Hunt LW, Gleich GJ, et al. Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils. J Immunol. 1998 Apr 15; 160(8): 4010-4017.
  29. Yardeni IZ, Beilin B, Mayburd E, Levinson Y, Bessler H. The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg. 2009 Nov; 109(5): 1464-1469. https://doi.org/10.1213/ANE.0b013e3181bab1bd
  30. Kandil E, Melikman E, Adinoff B. Lidocaine infusion: a promising therapeutic approach for chronic pain. Journal of anesthesia & clinical research. 2017; 8(1): 697. https://doi.org/10.4172/2155-6148.1000697
  31. Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011 Mar-Apr; 14(2): 145-161.
  32. Eipe, N, Gupta S, Penning J. Intravenous lidocaine for acute pain: an evidence-based clinical update. Bja Education. 2016; 16(9): 292-298. https://doi.org/10.1093/bjaed/mkw008
  33. Estebe J-P. Intravenous lidocaine. Best Pract Res Clin Anaesthesiol. 2017; 31(4): 513-521. https://doi.org/10.1016/j.bpa.2017.05.005
  34. Cavaleiro C, Gonçalves V, Pinho S, Miguel JC, Machado H. Intravenous Lidocaine Survey: Clinical Practice Impact of Published Data. J Anesth Clin Res. 2018; 9(803): 2.
  35. Chen K, Wei P, Zheng Q, Zhou J, Li J. Neuroprotective effects of intravenous lidocaine on earlypostoperative cognitive dysfunction in elderly patients following spine surgery. Med Sci Monit. 2015; 21: 1402-7. https://doi.org/10.12659/MSM.894384
  36. Dunn LK, Durieux ME Perioperative Use of Intravenous Lidocaine. Anesthesiology. 2017; 126: 729-737. https://doi.org/10.1097/ALN.0000000000001527
  37. Farag E, Ghobrial M, Sessler DI, Dalton JE, Liu J, Lee JH, et al. Effect of periopertaive intravenous lidocaine administration on pain, opioid consumption and quality of life after complex spine surgery. Anesthesiology. 2013; 119: 932-40. https://doi.org/10.1097/ALN.0b013e318297d4a5
  38. Weibel S, Jokinen J, Pace NL, Schnabel A, Hollmann MW, Hahnenkamp K, et al. Efficacy and safety of intravenous lidocaine for postoperative analgesia and recovery after surgery: a systematic review with trial sequential analysis. British journal of anaesthesia. 2016; 116(6): 770-783. https://doi.org/10.1093/bja/aew101
  39. Montandon G, Horner RL. Electrocortical changes associating sedation and respiratory depression by the opioid analgesic fentanyl. Sci Rep. 2019 Oct 1; 9(1): 14122. https://doi.org/10.1038/s41598-019-50613-2
  40. Ren J, Ding X, Greer JJ. Activating α4β2 Nicotinic Acetylcholine Receptors Alleviates Fentanyl-induced Respiratory Depression in Rats. Anesthesiology. 2019 Jun; 130(6): 1017-1031. https://doi.org/10.1097/ALN.0000000000002676
  41. Hill R, Santhakumar R, Dewey W, Kelly E, Henderson G. Fentanyl depression of respiration: comparison with heroin and morphine. Br J Pharmacol. 2020 Jan; 177(2): 254-266. https://doi.org/10.1111/bph.14860
  42. Armario A, Marti O, Molina T, de Pablo J, Valdes M. Acute stress markers in humans: response of plasma glucose, cortisol and prolactin to two examinations differing in the anxiety they provoke. Psychoneuroendocrinology. 1996 Jan; 21(1): 17-24. https://doi.org/10.1016/0306-4530(95)00048-8
  43. Kozlov AI, Kozlova MA. Kortizol kak marker stressa [Cortisol as a stress marker]. Fiziologiya cheloveka. 2014; 40(2): 123-123. [Russian] https://doi.org/10.1134/S0362119714020091
  44. Versaci F, Gaspardone A, Tomai F, Proietti I, Crea F, Chiariello L, et al. Chest pain after coronary artery stent implantation. The American Journal of Cardiology. 2002; 89(5): 500-504. https://doi.org/10.1016/S0002-9149(01)02287-1
  45. Smith HS, Laufer A. Opioid induced nausea and vomiting. Eur J Pharmacol. 2014 Jan 5; 722: 67-78. https://doi.org/10.1016/j.ejphar.2013.09.074
  46. Roberts GW, Bekker TB, Carlsen HH, Moffatt CH, Slattery PJ, McClure AF. Postoperative nausea and vomiting are strongly influenced by postoperative opioid use in a dose-related manner. Anesth Analg. 2005 Nov; 101(5): 1343-8. https://doi.org/10.1213/01.ANE.0000180204.64588.EC
  47. Gupta RK, Makkar R, Lamba PS. Comparison of effectiveness of intravenous palonosetron versus ondansetron in prevention of post-operative nausea and vomiting in laparoscopic surgeries under general anaesthesia: a randomised double blind interventional study. International Journal of Scientific Research. 2020; 9(1): 72-74.
  48. Yazbeck-Karam VG, Siddik-Sayyid SM, Barakat HB, Korjian S, Aouad MT. Haloperidol versus ondansetron for treatment of established nausea and vomiting following general anesthesia: a randomized clinical trial. Anesth Analg. 2017 Feb; 124(2): 438-444. https://doi.org/10.1213/ANE.0000000000001723